This fact sheet provides information about the use of the hormone oxytocin in the Uniject device to prevent postpartum hemorrhage. It summarizes the benefits of using this innovative solution and also provides a success story based on a pilot study conducted in Mali.
Corporate author(s): PATH, POPPHI
Publication date: November 2009
168 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA